Comparison of Metolazone Versus Chlorothiazide in Acute Decompensated Heart Failure with Diuretic Resistance

Cardiovascular Therapeutics

Volumn 33, Issue 2, 2015, Pages 42-49

  Moranville, Michael P ^a   Choi, Suji ^b   Hogg, Jennifer ^c   Anderson, Allen S ^d   Rich, Jonathan D ^d  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c ESKENAZI HEALTH   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chlorothiazide; Diuretics; Heart failure; Metolazone; Renal dysfunction

Indexed keywords

CHLOROTHIAZIDE; DIURETIC AGENT; FUROSEMIDE; LOOP DIURETIC AGENT; METOLAZONE; THIAZIDE DIURETIC AGENT;

ACUTE HEART FAILURE; ADD ON THERAPY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FEMALE; HOSPITAL PATIENT; HUMAN; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PACEMAKER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINE VOLUME; ACUTE DISEASE; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECTS; DRUG RESISTANCE; HEART FAILURE; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MICTURITION; MIDDLE AGED; NEPHRON; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; TIME; TREATMENT OUTCOME; UNITED STATES;

ACUTE DISEASE; ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; AGED; CHICAGO; CHLOROTHIAZIDE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; METOLAZONE; MIDDLE AGED; NEPHRONS; RETROSPECTIVE STUDIES; SODIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TIME FACTORS; TREATMENT OUTCOME; URINATION;

EID: 84925361856     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/1755-5922.12109     Document Type: Article

References (44)

1. Marik PE, Flemmer M. Narrative review: The management of acute decompensated heart failure. J Intensive Care Med 2012;27:343-353.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 2011;123:e18-e209.
3. Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, Emerman CL. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: Insights from the ADHERE registry. Cardiology 2009;113:12-19.
4. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-e90.
5. Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010;16:e1-e194.
6. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2013;62:e147-e239.
7. Majure DT, Teerlink JR. Update on the management of acute decompensated heart failure. Curr Treat Options Cardiovasc Med 2011;13:570-585.
8. Jentzer JC, DeWald TA, Hernandez AF. Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol 2010;56:1527-1534.
9. Ellison DH. The physiologic basis of diuretic synergism: Its role in treating diuretic resistance. Ann Intern Med 1991;114:886-894.
10. Asscher AW. Treatment of frusemide resistant edema with metolazone. Clin Trials J 1974;4:134-139.
11. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989;36:682-689.
12. Mouallem M, Brif I, Mayan H, Farfel Z. Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions. Int J Cardiol 1995;50:89-94.
13. Dormans TP, Gerlag PG. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 1996;17:1867-1874.
14. Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol 1995;26:394-400.
15. Tanaka M, Oida E, Nomura K. The Na+-excreting efficacy of indapamide in combination with furosemide in massive edema. Clin Exp Nephrol 2005;9:122-126.
16. Epstein MR, Lepp BA, Hoffman DS, Levinson R. Potentiation of furosemide by metolazone in refractory edema. Curr Ther Res 1977;21:656-667.
17. Fliser D, Schroter M, Neubeck M, Ritz E. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 1994;46:482-488.
18. Wollam GL, Tarazi RC, Bravo EL, Dustan HP. Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med 1982;72:929-938.
19. Kiyingi A, Field MJ, Pawsey CC, Yiannikas J, Lawrence JR, Arter WJ. Metolazone in treatment of severe refractory congestive cardiac failure. Lancet 1990;335:29-31.
20. Ram CVS, Reichgott MJ. Treatment of loop-diuretic resistant edema by the addition of metolazone. Curr Ther Res 1977;22:686-691.
21. Gunstone RF, Wing AJ, Shani HG, Njemo D, Sabuka EM. Clinical experience with metolazone in fifty-two African patients: Synergy with frusemide. Postgrad Med J 1971;47:789-793.
22. Channer KS, McLean KA, Lawson-Matthew P, Richardson M. Combination diuretic treatment in severe heart failure: A randomised controlled trial. Br Heart J 1994;71:146-150.
23. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
24. Chlorothiazide (Diuril®) [package insert]. Minneapolis, MN: Salix Pharmaceuticals, Inc, 2011.
25. Metolazone (Zaroxolyn) [package insert]. Laval, QC, Canada: Sanofi-Aventis, Inc, 2006.
26. Barsuk JH, Gordon RA, Cohen ER, Cotts WG, Malkenson D, Yancy CW, Williams MV. A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure. Congest Heart Fail 2013;19:53-60.
27. Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675-683.
28. Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO. Rehospitalization for heart failure: Problems and perspectives. J Am Coll Cardiol 2013;61:391-403.
29. Thavendiranathan P, Yingchoncharoen T, Grant A, Seicean S, Landers SH, Gorodeski EZ, Marwick TH. Prediction of 30-day heart failure-specific readmission risk by echocardiographic parameters. Am J Cardiol 2013;113:335-341.
30. Ambrosy AP, Pang PS, Khan S, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: Findings from the EVEREST trial. Eur Heart J 2013;34:835-843.
31. Kociol RD, McNulty SE, Hernandez AF, et al. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail 2013;6:240-245.
32. Sharma GV, Woods PA, Lindsey N, O'Connell C, Connolly L, Joseph J, McIntyre KM. Noninvasive monitoring of left ventricular end-diastolic pressure reduces rehospitalization rates in patients hospitalized for heart failure: A randomized controlled trial. J Card Fail 2011;17:718-725.
33. Pimenta J, Paulo C, Mascarenhas J, Gomes A, Azevedo A, Rocha-Goncalves F, Bettencourt P. BNP at discharge in acute heart failure patients: Is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status. Int J Cardiol 2010;145:209-214.
34. Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012;367:2296-2304.
35. Rudy DW, Voelker JR, Greene PK, Esparza FA, Brater DC. Loop diuretics for chronic renal insufficiency: A continuous infusion is more efficacious than bolus therapy. Ann Intern Med 1991;115:360-366.
36. Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011;364:797-805.
37. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis. JAMA 2005;293:572-580.
38. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118, 465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database. J Card Fail 2007;13:422-430.
39. Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005;46:57-64.
40. Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 2008;52:347-356.
41. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-1847.
42. Red book: pharmacy's fundamental reference. New York, NY: Thomson Reuters, 2011.
43. Lau BW, Pinto BL, Thiemann DR, Lehmann CU. Budget impact analysis of conversion from intravenous to oral medication when clinically eligible for oral intake. Clin Ther 2011;33:1792-1796.
44. Fida N, Pina IL. Trends in heart failure hospitalizations. Curr Heart Fail Rep 2012;9:346-353.